AIDS-Related Progressive Multifocal Leukoencephalopathy in the Era of HAART: Report of Two Cases and Review of the Literature
- 1 August 2005
- journal article
- case report
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 19 (8) , 486-494
- https://doi.org/10.1089/apc.2005.19.486
Abstract
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system. It is caused by the JC virus (JCV), a human polyomavirus replicating in human glial cells. PML is the result of the reactivation of latent JCV infection that usually occurs in the setting of cellular immunodeficiencies such as HIV-1 infection. Epidemiologic data suggest that the impact of highly active antiretroviral therapy (HAART) on the incidence of PML is less profound than seen with other opportunistic infections. Given the lack of an effective and specific therapy for PML, HAART remains the only therapeutic option in patients with PML. However, a significant number of cases appear unresponsive to antiretroviral therapy. Moreover, there is growing data on unexpected inflammatory cases of PML after initiation of HAART. Thus, PML will remain a relevant cause of morbidity and mortality in HIV- 1–infected patients. Here we report two cases of PML, along with a concise review of the literature on this important disease.Keywords
This publication has 72 references indexed in Scilit:
- Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatmentJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2003
- The Effect of Potent Antiretroviral Therapy and JC Virus Load in Cerebrospinal Fluid on Clinical Outcome of Patients with AIDS‐Associated Progressive Multifocal LeukoencephalopathyThe Journal of Infectious Diseases, 2000
- Quantification of JC Virus DNA in the Cerebrospinal Fluid of Patients with Human Immunodeficiency Virus–Associated Progressive Multifocal Leukoencephalopathy—A Longitudinal StudyThe Journal of Infectious Diseases, 1999
- Predictive factors for prolonged survival in acquired immunodeficiency syndrome—associated progressive multifocal leukoencephalopathyAnnals of Neurology, 1998
- Efficacy of camptothecin in progressive multifocal leucoencephalopathyThe Lancet, 1997
- Human T lymphotropic virus, type-I myelopathyCurrent Opinion in Neurology, 1995
- Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluidAIDS, 1994
- Progressive Multifocal Leukoencephalopathy in a Male Homosexual with T-Cell Immune DeficiencyNew England Journal of Medicine, 1982
- PROGRESSIVE MULTIFOCAL LEUKO-ENCEPHALOPATHYBrain, 1958